Speaker, thank you very much, Mr Waters. We haven't done that kind of a study yet. At the moment, as I said, we will only be able to announce the extension of treatment to those with a CD4 count of 350 by 12 August this year. That was based on a costing exercise conducted by the Ministry of Health and by National Treasury. We haven't gone that far. That is the step that, I suppose, we'll have to take in the near future.
Our effort is really also aimed at ensuring that we reduce new infections through spreading the word and ensuring that we prevent new infections and place more people on treatment - if that is outstripped by the rate of new infections, it means that we are not winning the battle. That is what is preoccupying Sanac at this point in time. Thank you.